The FDA's stamp of approval is being sought for a new drug, ONCONASE, that is designed to treat patients with unresectable malignant mesothelioma (UMM).
: http://mesothelioma.clarislaw.com/mesothelioma-news/onconasea-new-prospect-for-mesothelioma-victims.php